Wei Gao

7PUBLICATIONS
21CO-AUTHORS
Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Tumour immunologyBiologically active moleculesCancer therapy (excl. chemotherapy and radiation therapy)Gene and molecular therapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Apr 28, 2026
Dual targeting of PI3Kγ and STING overcomes regulatory B cell- and myeloid cell-driven immune suppression in pancreatic cancer.

|Feb 13, 2025
SARS-CoV-2 B Epitope-Guided Neoantigen NanoVaccines Enhance Tumor-Specific CD4/CD8 T Cell Immunity through B Cell Antigen Presentation.

Chengyi Li, Fang Ke, Shuai Mao

|Feb 11, 2025
A pH-Responsive and Guanidinium-Rich Nanoadjuvant Efficiently Delivers STING Agonist for Cancer Immunotherapy.

Xiao Lu, Heming Xia, Wei Gao

|Mar 21, 2024
Antigen-Clustered Nanovaccine Achieves Long-Term Tumor Remission by Promoting B/CD 4 T Cell Crosstalk.

Chengyi Li, Ryan Clauson, Luke F Bugada

|Sep 07, 2022
Optimization of the Prodrug Moiety of Remdesivir to Improve Lung Exposure/Selectivity and Enhance Anti-SARS-CoV-2 Activity.

Hongxiang Hu, Mohamed Dit Mady Traore, Ruiting Li

|May 04, 2022
Albumin nanoparticle containing a PI3Kγ inhibitor and paclitaxel in combination with α-PD1 induces tumor remission of breast cancer in mice.

Yudong Song, Luke Bugada, Ruiting Li

Pageof 2

Frequent Collaborators

5 joint publications

Duxin Sun

3 joint publications

Chengyi Li

2 joint publications

Yudong Song

2 joint publications

Hebao Yuan